Biotech IV Monitor

INDV — Indivior Pharmaceuticals Inc.

$5.1B market cap · 0 upcoming readouts tracked

Clinical trial readout dates for Indivior Pharmaceuticals Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced.

Market cap$5.1B
Cash & investments$305Mas of Sep 30, 2026
Recent 8-K filings3latest 2026-11-03

In progress, no date published

Phase 2 INDV-6001
Opioid Use Disorder (OUD)
date not published
Ongoing

Cash position

Indivior Pharmaceuticals Inc. reported $305M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-10-29). It reported net income of $137M for that quarter.

Recent SEC filings

8-K Other Events — often topline trial data2026-11-03
8-K Reg FD Disclosure — often a data announcement2026-11-02
8-K Results of Operations — earnings, may carry pipeline updates2026-10-29

Discussion

No messages yet. If you follow INDV, you can start the conversation.
Track INDV in real time
See live implied volatility for INDV and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on INDV
Contact — questions or corrections about INDV: dukeupt@gmail.com